Newsfeeds - Spark Newswire

2 minute read

Earnings

Milestone Scientific Earnings Perspective: Return On Capital Employed

Today, 3:36 PM

According to Benzinga Pro data, during Q4, Milestone Scientific (AMEX:MLSS) posted sales of $2.85 million. Earnings were up 44.62%, but Milestone Scientific still reported an overall loss of $1.14 million.

MLSS

3 minute read

A Peek Into The Markets: US Stock Futures Higher; All Eyes On Jobs Data

By Lisa Levin

Today, 3:36 PM

Pre-open movers

AEHR

1 minute read

5 Stocks To Watch For April 1, 2022

By Lisa Levin

Today, 3:36 PM

Some of the stocks that may grab investor focus today are: Wall Street expects Yatra Online, Inc. (NASDAQ: YTRA) to report a quarterly loss at $0.02 per share on revenue of $11.84 million before the opening bell. Yatra Online shares gained 2.5% to $2.03 in after-hours trading.

AEHR

2 minute read

Milestone Scientific Commences Sales Of CompuFlo Epidural Disposables Within Prominent Pain Clinic With Leading Physician

By Benzinga Newsdesk

Today, 3:36 PM

Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that Dr. Harsh Govil, MD, MPH, whose

MLSS

1 minute read

News

Milestone Scientific Announces Purchase Of CompuFlo / CathCheck Verification System Disposables At Two Additional Premier Hospitals

By Bill Haddad

Today, 3:36 PM

ROSELAND, N.J., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today

MLSS

2 minute read

Milestone Scientific Wins Purchase Deal With Premier Northeast Teaching Hospital for Co.’s CompuFlo Epidural/CathCheck Verification System Disposables, No Terms Disclosed

By Benzinga Newsdesk

Today, 3:36 PM

Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported, that following a successful trial, it has signed an

MLSS

1 minute read

From Benzinga’s All-Access Conference: Milestone Scientific CEO, Arjan Haverhals Says Co Is Financially ‘Very’ Healthy, Co Has Enough Cash On Hands To Operate In The Next Two Years, Says Co Does Not Have Any Long-Term Debts

By Benzinga Newsdesk

Today, 3:36 PM

https://www.youtube.com/watch?v=FHUuAwo4G1g

MLSS

4 minute read

The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More

By Shanthi Rexaline

Today, 3:36 PM

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.

ACRX

1 minute read

Earnings

Earnings Outlook For Milestone Scientific

By Benzinga Insights

Today, 3:36 PM

Milestone Scientific (AMEX:MLSS) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement. Analysts estimate that Milestone Scientific will likely report an Earnings Per Share (EPS) of $-0.02

MLSS

2 minute read

Earnings

Milestone Scientific’s Return On Capital Employed Overview

By Benzinga Insights

Today, 3:36 PM

Benzinga Pro data, Milestone Scientific (AMEX:MLSS) reported Q2 sales of $2.43 million. Earnings fell to a loss of $2.87 million, resulting in a 191.82% decrease from last quarter.

MLSS